Virtus ETF Advisers’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2,526
| Closed | -$67.4K | – | 411 |
|
|
2024
Q4 | $67.4K | Sell |
2,526
-2,619
| -51% | -$69.9K | 0.03% | 402 |
|
|
2024
Q3 | $137K | Buy |
5,145
+91
| +2% | +$2.43K | 0.06% | 336 |
|
|
2024
Q2 | $91K | Buy |
+5,054
| New | +$91K | 0.04% | 355 |
|
|
2023
Q4 | – | Sell |
-10,384
| Closed | -$59.5K | – | 441 |
|
|
2023
Q3 | $59.5K | Sell |
10,384
-1,038
| -9% | -$5.95K | 0.04% | 404 |
|
|
2023
Q2 | $88.5K | Sell |
11,422
-1,085
| -9% | -$8.41K | 0.05% | 419 |
|
|
2023
Q1 | $83.4K | Sell |
12,507
-4,807
| -28% | -$32.1K | 0.05% | 380 |
|
|
2022
Q4 | $155K | Sell |
17,314
-155
| -0.9% | -$1.39K | 0.08% | 338 |
|
|
2022
Q3 | $172K | Buy |
17,469
+128
| +0.7% | +$1.26K | 0.07% | 333 |
|
|
2022
Q2 | $138K | Buy |
17,341
+9,212
| +113% | +$73.3K | 0.05% | 332 |
|
|
2022
Q1 | $79K | Sell |
8,129
-475
| -6% | -$4.62K | 0.04% | 341 |
|
|
2021
Q4 | $131K | Buy |
+8,604
| New | +$131K | 0.05% | 366 |
|